Thumbs Down From FDA Panel on Plastic Meniscus Replacement
An FDA advisory committee voted 6-2, with one absention, that a novel, synthetic knee meniscus replacement’s benefits do not outweigh its risks, and thus is not suitable for marketing. Members of the Orthopaedic and Rehabilitation Devices Panel of the FDA’s Medical Devices Advisory Committee said the efficacy data were too weak, and a nearly 50% […]